1 - 3 of 3
1
Conference item icon

Conference item

Modelling peripheral blood eosinophils to identify response to budesonide in COPD: a post-hoc analysis

  • Conference abstract
  • Bafadhel, M, Peterson, S, De Blas, M, et al.
  • 2017-12-06
2
Conference item icon

Conference item

Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS)

  • Bafadhel, M, Sing, D, Jenkins, C, et al.
  • 2018-11-19
3
Conference item icon

Conference item

Adding budesonide to formoterol reduces risk of clinically important deteriorations (CID) in moderate to very severe COPD

  • Bengtsson, T, Peterson, S, Jenkins, C, et al.
  • 2018-11-19
FILTER RESULTS

TO TOP